Medical devices, SMEs in healthcare: 4,000 companies at risk of default due to new tax – reports LaPresse
Globe Newswire23-09-2024, 22:05
FDA approves biosimilar Pyzchiva® (ustekinumab-ttwe), to be commercialized by Sandoz in US 1-07-2024, 12:00